These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24340105)

  • 1. Over-expression of 60s ribosomal L23a is associated with cellular proliferation in SAG resistant clinical isolates of Leishmania donovani.
    Das S; Shah P; Baharia RK; Tandon R; Khare P; Sundar S; Sahasrabuddhe AA; Siddiqi MI; Dube A
    PLoS Negl Trop Dis; 2013; 7(12):e2527. PubMed ID: 24340105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Over-Expression of Cysteine Leucine Rich Protein Is Related to SAG Resistance in Clinical Isolates of Leishmania donovani.
    Das S; Shah P; Tandon R; Yadav NK; Sahasrabuddhe AA; Sundar S; Siddiqi MI; Dube A
    PLoS Negl Trop Dis; 2015 Aug; 9(8):e0003992. PubMed ID: 26295340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteome mapping of overexpressed membrane-enriched and cytosolic proteins in sodium antimony gluconate (SAG) resistant clinical isolate of Leishmania donovani.
    Kumar A; Sisodia B; Misra P; Sundar S; Shasany AK; Dube A
    Br J Clin Pharmacol; 2010 Oct; 70(4):609-17. PubMed ID: 20840452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the proliferating cell nuclear antigen of Leishmania donovani clinical isolates and its association with antimony resistance.
    Tandon R; Chandra S; Baharia RK; Das S; Misra P; Kumar A; Siddiqi MI; Sundar S; Dube A
    Antimicrob Agents Chemother; 2014 Jun; 58(6):2997-3007. PubMed ID: 24614385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmania donovani isolates with antimony-resistant but not -sensitive phenotype inhibit sodium antimony gluconate-induced dendritic cell activation.
    Haldar AK; Yadav V; Singhal E; Bisht KK; Singh A; Bhaumik S; Basu R; Sen P; Roy S
    PLoS Pathog; 2010 May; 6(5):e1000907. PubMed ID: 20502630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased parasite surface antigen-2 expression in clinical isolates of Leishmania donovani augments antimony resistance.
    Bhandari V; Kumar D; Verma S; Srividya G; Negi NS; Singh R; Salotra P
    Biochem Biophys Res Commun; 2013 Nov; 440(4):646-51. PubMed ID: 24103752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of ABC transporters abolishes antimony resistance in Leishmania Infection.
    Mookerjee Basu J; Mookerjee A; Banerjee R; Saha M; Singh S; Naskar K; Tripathy G; Sinha PK; Pandey K; Sundar S; Bimal S; Das PK; Choudhuri SK; Roy S
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1080-93. PubMed ID: 18056276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of genetic markers in sodium antimony gluconate (SAG) sensitive and resistant Indian clinical isolates of Leishmania donovani through amplified fragment length polymorphism (AFLP).
    Kumar A; Boggula VR; Sundar S; Shasany AK; Dube A
    Acta Trop; 2009 Apr; 110(1):80-5. PubMed ID: 19283900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani.
    Lira R; Sundar S; Makharia A; Kenney R; Gam A; Saraiva E; Sacks D
    J Infect Dis; 1999 Aug; 180(2):564-7. PubMed ID: 10395884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of ABC transporter MRPA, gamma-glutamylcysteine synthetase and ornithine decarboxylase in natural antimony-resistant isolates of Leishmania donovani.
    Mukherjee A; Padmanabhan PK; Singh S; Roy G; Girard I; Chatterjee M; Ouellette M; Madhubala R
    J Antimicrob Chemother; 2007 Feb; 59(2):204-11. PubMed ID: 17213267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on stibanate resistant Leishmania donovani isolates of Indian origin.
    Pal S; Mandal A; Duttagupta S
    Indian J Exp Biol; 2001 Mar; 39(3):249-54. PubMed ID: 11495284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic typing reveals monomorphism between antimony sensitive and resistant Leishmania donovani isolates from visceral leishmaniasis or post kala-azar dermal leishmaniasis cases in India.
    Subba Raju BV; Gurumurthy S; Kuhls K; Bhandari V; Schnonian G; Salotra P
    Parasitol Res; 2012 Oct; 111(4):1559-68. PubMed ID: 22752721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of antimony-resistant Leishmania donovani isolates: biochemical and biophysical studies and interaction with host cells.
    Mukhopadhyay R; Mukherjee S; Mukherjee B; Naskar K; Mondal D; Decuypere S; Ostyn B; Prajapati VK; Sundar S; Dujardin JC; Roy S
    Int J Parasitol; 2011 Nov; 41(13-14):1311-21. PubMed ID: 21920365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased metacyclogenesis of antimony-resistant Leishmania donovani clinical lines.
    Ouakad M; Vanaerschot M; Rijal S; Sundar S; Speybroeck N; Kestens L; Boel L; De Doncker S; Maes I; Decuypere S; Dujardin JC
    Parasitology; 2011 Sep; 138(11):1392-9. PubMed ID: 21819638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteophosphoglycan is differentially expressed in sodium stibogluconate-sensitive and resistant Indian clinical isolates of Leishmania donovani.
    Samant M; Sahasrabuddhe AA; Singh N; Gupta SK; Sundar S; Dube A
    Parasitology; 2007 Aug; 134(Pt 9):1175-84. PubMed ID: 17362540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sub-optimal dose of Sodium Antimony Gluconate (SAG)-diperoxovanadate combination clears organ parasites from BALB/c mice infected with antimony resistant Leishmania donovani by expanding antileishmanial T-cell repertoire and increasing IFN-gamma to IL-10 ratio.
    Haldar AK; Banerjee S; Naskar K; Kalita D; Islam NS; Roy S
    Exp Parasitol; 2009 Jun; 122(2):145-54. PubMed ID: 19422069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating genomics and proteomics permits identification of immunodominant antigens associated with drug resistance in human visceral leishmaniasis in India.
    Singh N; Sundar S
    Exp Parasitol; 2017 May; 176():30-45. PubMed ID: 28263760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmania donovani: CD2 biased immune response skews the SAG mediated therapy for a predominant Th1 response in experimental infection.
    Bimal S; Sinha S; Singh SK; Narayan S; Kumar V; Verma N; Ranjan A; Sinha PK; Das VN; Pandey K; Kar SK; Das P
    Exp Parasitol; 2012 Jul; 131(3):274-82. PubMed ID: 22580024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remarks on identification of amplified fragment length polymorphisms linked to SAG resistance in Leishmania.
    Van der Auwera G; Bhattarai NR; Odiwuor S; Vuylsteke M
    Acta Trop; 2010 Jan; 113(1):92-3. PubMed ID: 19800857
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro susceptibility of field isolates of Leishmania donovani to Miltefosine and amphotericin B: correlation with sodium antimony gluconate susceptibility and implications for treatment in areas of endemicity.
    Kumar D; Kulshrestha A; Singh R; Salotra P
    Antimicrob Agents Chemother; 2009 Feb; 53(2):835-8. PubMed ID: 19015344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.